MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA. New data from…
Category:
Investing
-
-
Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for traders, including mining and defense stocks, reports on how critical mineral antimony is gaining government and investor attention as its…
-
United States Antimony (NYSE:UAMY) said on Sunday (October 19) that it is proposing to acquire Australian company Larvotto Resources (ASX:LRV). In a takeover offer, USAC said that it would pay…
-
Investing
Cartier Cuts 11.0 g/t Au over 9.0 m including 30.2 g/t Au over 2.5 at Contact ; Continues to Expand High-Grade Gold North Contact Zone near Surface
by adminby adminCartier Resources Inc. (″ Cartier ″ or the ″ Company ″) (TSXV: ECR,OTC:ECRFF; FSE: 6CA) is pleased to announce the third batch of results from the fully funded 100,000-m drilling…
-
Not for distribution to United States newswire services or for dissemination in the United States Fortune Bay Corp. (TSXV: FOR,OTC:FTBYF) (FWB: 5QN) (OTCQB: FTBYF) (‘Fortune Bay’ or the ‘Company’) is…
-
-
Morgan Stanley (NYSE:MS) recently recommended that investors consider a 60-20-20 portfolio where 20 percent is allocated to gold. Rich Checkan, president and COO of Asset Strategies International, crunches the numbers,…
-
-
-
Investing
Torchlight Innovations (Doing Business as RZOLV Technologies) Announces Preliminary Positive Results on Rare Earth and Critical Mineral Recoveries
by adminby adminTorchlight Innovations Inc. (TSXV: TLX.P) (‘Torchlight’ or ‘the Company’), doing business as RZOLV Technologies, is pleased to announce positive preliminary results from its metallurgical testing program focused on rare earth…